Juergen Scharner

971 total citations
13 papers, 712 citations indexed

About

Juergen Scharner is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Juergen Scharner has authored 13 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 1 paper in Surgery and 1 paper in Genetics. Recurrent topics in Juergen Scharner's work include RNA Research and Splicing (8 papers), Nuclear Structure and Function (6 papers) and RNA modifications and cancer (3 papers). Juergen Scharner is often cited by papers focused on RNA Research and Splicing (8 papers), Nuclear Structure and Function (6 papers) and RNA modifications and cancer (3 papers). Juergen Scharner collaborates with scholars based in United Kingdom, United States and Russia. Juergen Scharner's co-authors include Peter S. Zammit, Isabel Aznarez, Juliet A. Ellis, Frank Rigo, C. Frank Bennett, Wai Kit, Kuan‐Ting Lin, Adrian R. Krainer, Hyun Yong Jeon and Viola F. Gnocchi and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Juergen Scharner

13 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juergen Scharner United Kingdom	13	625	102	81	76	53	13	712
Shehla Mohammed United Kingdom	12	497 0.8×	55 0.5×	248 3.1×	92 1.2×	42 0.8×	25	680
Ralitsa Petrova United States	8	517 0.8×	45 0.4×	128 1.6×	47 0.6×	37 0.7×	11	678
Hernán Gonorazky Canada	12	532 0.9×	208 2.0×	182 2.2×	30 0.4×	75 1.4×	43	710
Oliver Hummel Germany	14	664 1.1×	47 0.5×	97 1.2×	59 0.8×	84 1.6×	20	811
Guilai Shi China	12	720 1.2×	92 0.9×	91 1.1×	56 0.7×	208 3.9×	15	902
Cécile Peccate France	15	560 0.9×	86 0.8×	112 1.4×	15 0.2×	42 0.8×	25	661
Jaya Punetha United States	11	319 0.5×	85 0.8×	139 1.7×	16 0.2×	31 0.6×	15	437
Alice Steinbrecher Germany	5	638 1.0×	66 0.6×	93 1.1×	27 0.4×	48 0.9×	7	725
Monize Lazar Brazil	9	292 0.5×	72 0.7×	129 1.6×	28 0.4×	42 0.8×	14	464
Diane Golebiowski United States	10	378 0.6×	79 0.8×	109 1.3×	91 1.2×	17 0.3×	13	485

Countries citing papers authored by Juergen Scharner

Since Specialization

Citations

This map shows the geographic impact of Juergen Scharner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Scharner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Scharner more than expected).

Fields of papers citing papers by Juergen Scharner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Scharner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Scharner. The network helps show where Juergen Scharner may publish in the future.

Co-authorship network of co-authors of Juergen Scharner

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Scharner. A scholar is included among the top collaborators of Juergen Scharner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Scharner. Juergen Scharner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kit, Wai, Juergen Scharner, Ana S.H. Costa, et al.. (2021). ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth. Cancer Research. 82(5). 900–915. 79 indexed citations

Lim, Kian‐Huat, Han Zhou, Hyun Yong Jeon, et al.. (2020). Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression. Nature Communications. 11(1). 3501–3501. 138 indexed citations

Scharner, Juergen & Isabel Aznarez. (2020). Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics. Molecular Therapy. 29(2). 540–554. 69 indexed citations

Scharner, Juergen, et al.. (2019). Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor. Molecular Therapy — Nucleic Acids. 16. 313–325. 25 indexed citations

Scharner, Juergen, Wai Kit, Qian Zhang, et al.. (2019). Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides. Nucleic Acids Research. 48(2). 802–816. 65 indexed citations

Lin, Kuan‐Ting, Wai Kit, Juergen Scharner, Yun-Ru Liu, & Adrian R. Krainer. (2018). A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma. Genome Research. 28(3). 275–284. 17 indexed citations

Scharner, Juergen, Nicolas Figeac, Juliet A. Ellis, & Peter S. Zammit. (2015). Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies. Gene Therapy. 22(6). 503–515. 31 indexed citations

Scharner, Juergen, Hui‐Chun Lu, Franca Fraternali, Juliet A. Ellis, & Peter S. Zammit. (2013). Mapping disease‐related missense mutations in the immunoglobulin‐like fold domain of lamin A/C reveals novel genotype–phenotype associations for laminopathies. Proteins Structure Function and Bioinformatics. 82(6). 904–915. 22 indexed citations

Brown, Charlotte A., Juergen Scharner, Kevin J. Felice, et al.. (2011). Novel and recurrent EMD mutations in patients with Emery–Dreifuss muscular dystrophy, identify exon 2 as a mutation hot spot. Journal of Human Genetics. 56(8). 589–594. 26 indexed citations

10.

Gnocchi, Viola F., Juergen Scharner, Zhe Huang, et al.. (2011). Uncoordinated Transcription and Compromised Muscle Function in the Lmna-Null Mouse Model of Emery-Dreifuss Muscular Dystrophy. PLoS ONE. 6(2). e16651–e16651. 22 indexed citations

11.

Scharner, Juergen & Peter S. Zammit. (2011). The muscle satellite cell at 50: the formative years. Skeletal Muscle. 1(1). 28–28. 128 indexed citations

12.

Scharner, Juergen, Charlotte A. Brown, Matthew Bower, et al.. (2010). Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations. Human Mutation. 32(2). 152–167. 55 indexed citations

13.

Scharner, Juergen, Viola F. Gnocchi, Juliet A. Ellis, & Peter S. Zammit. (2010). Genotype–phenotype correlations in laminopathies: how does fate translate?. Biochemical Society Transactions. 38(1). 257–262. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact